Press release
Myelofibrosis Therapeutics Pipeline 2017 - Key Players Analysis CTI BioPharma, Geron Corporation, Gilead Sciences
The study analysed that the therapeutics pipeline comprises of approximately 29 drug candidates in different stages of development.Myelofibrosis is a rare disorder in which excessive scar tissue gets formed in the bone marrow that impairs its ability to produce red blood cells. However, it is believed by researchers that myelofibrosis occurs due to the presence of abnormal red blood stem cells in the bone marrow. The abnormal blood stem cells produce mature cells that grow quickly and form scar tissue which leads to chronic inflammation.
Browse report sample at: https://www.psmarketresearch.com/market-analysis/myelofibrosis-therapeutics-pipeline-analysis/report-sample
Various companies, educational institutes and medical organization are collaborating for the development of therapeutics for the treatment of myelofibrosis. For instance, Geron Corporation and Janssen Pharmaceuticals, Inc. entered into a collaboration agreement, in which Geron Corporation granted an exclusive worldwide right to Janssen, for the development and commercialization of imetelstat for all human therapeutic uses, including hematologic myeloid malignancies.
Pre-Purchase Inquiry at: https://www.psmarketresearch.com/send-enquiry?enquiry-url=myelofibrosis-therapeutics-pipeline-analysis
*Various drug candidates are being developed as small molecule
According to the research, there are several companies having drug candidates in their pipeline, using synthetic sources for the development of drugs for the treatment of myelofibrosis. Imetelstat is an oligonucleotide obtained from synthetic source that acts as telomerase inhibitor.
Browse report at: https://www.psmarketresearch.com/market-analysis/myelofibrosis-therapeutics-pipeline-analysis
Some of the key players developing drugs for myelofibrosis include CTI BioPharma Corporation, Geron Corporation, Gilead Sciences, Inc. and others.
About P&S Intelligence
P&S Intelligence, a brand of P&S Market Research, is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.
Contact:
P&S Intelligence
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Myelofibrosis Therapeutics Pipeline 2017 - Key Players Analysis CTI BioPharma, Geron Corporation, Gilead Sciences here
News-ID: 1417244 • Views: …
More Releases for P&S
Only 17 Stocks in the S&P 500 Have Outperformed the S&P 500 Index in EACH of the …
Image: https://www.getnews.info/wp-content/uploads/2024/04/1711974100.png
Washington, DC - April 1, 2024 - 17 stocks in the S&P 500 have consistently beaten the performance of the S&P 500 index on an annual basis over each of the last 4 years. At StoxxUSA.org, our equity analysis team has identified these StoxxUSA "Stars" which have beaten their respective index in each of the last 4 years.
Image: https://www.getnews.info/uploads/e8f37ff33afc4fe8e335ecca5313f8f4.jpg
The S&P "Stars" Report is prepared by StoxxUSA.org. StoxxUSA.org is not…
Europe is Dominating Glycolic Acid Industry - P&S Intelligence
The glycolic acid market was valued at USD 309.3 million in 2021, and it is set to reach USD 604.4 million by 2030, growing at a CAGR of 7.7% between 2021 and 2030, according to a research report by a market research company P&S Intelligence.
In 2021, the personal care and cosmetics category held the largest market share at 58.2%. this is due to glycolic acid being extensively utilized in skincare…
Immunotherapy Drugs Market Opportunity Assessment Study - P&S Intelligence
Hospitals and clinics were the key end users in the immunotherapy drugs market, with 81.0% contribution in 2017. The adoption of immunotherapy drugs has been increasing in hospitals and clinics, owing to growing patient population, increasing healthcare expenditure, and rising prevalence of chronic diseases, leading to dominate the end-user segment.
North America was the largest immunotherapy drugs market during the historical period, with more than 50.0% contribution in 2017. This can…
Neurostimulation Device Market Opportunity Assessment Study - P&S Intelligence
The neurostimulation device market is growing, due to increasing geriatric population, increasing prevalence of chronic pain, and increasing incidents of neurological disorders. In addition, the awareness about mental diseases and their treatment is also increasing across the globe.
Explore Report with Detailed TOC on “Global Neurostimulation Device Market” at: https://www.psmarketresearch.com/market-analysis/neurostimulation-devices-market
The information and data in the publication “Global Neurostimulation Device Market Size, Share, Development, Growth and Demand Forecast to 2022” represent the…
P&S Market Research
Isobutanol is expected to perceive significant demand as an alternative to conventional fuel. The high demand of the product is attributed to its increasing adoption as an alternative for ethanol in gasoline. It is widely used in the production of isobutyl acetate. The isobutanol market is driven by wide acceptance in the various consumer product industries, such as food processing industry and lacquer.
Get Sample Copy of This Report @https://www.psmarketresearch.com/market-analysis/isobutanol-market/report-sample
On the…
P&S Market Research
Supercapacitor Market Size, Share, Development, Growth and Demand Forecast to 2020
The growing need for increased battery life in smartphone, laptop, and other similar consumer electronics products has increased the market penetration of supercapacitors in various new applications. Supercapacitors are now used for the extended battery backup in smartphone, and laptops; moreover, the replacement of conventional capacitor with them is expected to drive the growth of the global market during the…